Benjamin Cravatt - Net Worth and Insider Trading

Benjamin Cravatt Net Worth

The estimated net worth of Benjamin Cravatt is at least $11,023 dollars as of 2024-11-13. Benjamin Cravatt is the Director of FibroGen Inc and owns about 28,736 shares of FibroGen Inc (FGEN) stock worth over $11,023. Details can be seen in Benjamin Cravatt's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Benjamin Cravatt has not made any transactions after 2023-06-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Benjamin Cravatt

To

Benjamin Cravatt Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Benjamin Cravatt owns 1 companies in total, including FibroGen Inc (FGEN) .

Click here to see the complete history of Benjamin Cravatt’s form 4 insider trades.

Insider Ownership Summary of Benjamin Cravatt

Ticker Comapny Transaction Date Type of Owner
FGEN FibroGen Inc 2023-06-09 director

Benjamin Cravatt Latest Holdings Summary

Benjamin Cravatt currently owns a total of 1 stock. Benjamin Cravatt owns 28,736 shares of FibroGen Inc (FGEN) as of June 9, 2023, with a value of $11,023.

Latest Holdings of Benjamin Cravatt

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FGEN FibroGen Inc 2023-06-09 28,736 0.38 11,023

Holding Weightings of Benjamin Cravatt


Benjamin Cravatt Form 4 Trading Tracker

According to the SEC Form 4 filings, Benjamin Cravatt has made a total of 1 transactions in FibroGen Inc (FGEN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in FibroGen Inc is the sale of 3,944 shares on June 9, 2023, which brought Benjamin Cravatt around $67,719.

Insider Trading History of Benjamin Cravatt

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Benjamin Cravatt Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Benjamin Cravatt Ownership Network

Ownership Network List of Benjamin Cravatt

No Data

Ownership Network Relation of Benjamin Cravatt

Insider Network Chart

Benjamin Cravatt Owned Company Details

What does FibroGen Inc do?

Who are the key executives at FibroGen Inc?

Benjamin Cravatt is the director of FibroGen Inc. Other key executives at FibroGen Inc include Chief Commercial Officer Thane Wettig , director & Chief Executive Officer Enrique A Conterno , and SVP & China Operations Christine Chung .

FibroGen Inc (FGEN) Insider Trades Summary

Over the past 18 months, Benjamin Cravatt made no insider transaction in FibroGen Inc (FGEN). Other recent insider transactions involving FibroGen Inc (FGEN) include a net purchase of 45,693 shares made by Thane Wettig , a net sale of 13,000 shares made by Jeffrey William Henderson , and a net sale of 16,133 shares made by Christine Chung .

In summary, during the past 3 months, insiders sold 0 shares of FibroGen Inc (FGEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 88,750 shares of FibroGen Inc (FGEN) were sold and 72,123 shares were bought by its insiders, resulting in a net sale of 16,627 shares.

FibroGen Inc (FGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

FibroGen Inc Insider Transactions

No Available Data

Benjamin Cravatt Mailing Address

Above is the net worth, insider trading, and ownership report for Benjamin Cravatt. You might contact Benjamin Cravatt via mailing address: C/o Fibrogen, Inc., 409 Illinois Street, San Francisco Ca 94158.